- Improved Mitral Regurgitation Outcomes Following Mitral Valve TEER
- Exercise Stress Testing in Pediatric Hypertrophic Cardiomyopathy
- Study Results Support COVID-19 Vaccination in Pregnant Women With Rheumatic Disease
- Continuing ACE Inhibitors Despite Potassium Change Can Have Benefits
- Serum 25(OH)D Levels Linked to Diabetes in African-Americans
- Isolated Nail Psoriasis Does Not Increase Risk for Metabolic Syndrome
- Low HDL-C Linked to Coronary Heart Disease Risk in White Adults
- Cognitive Scores Lower for Children With Iron Deficiency
- Paclitaxel-Eluting Stent for Treating Symptomatic Femoropopliteal PAD
- Sex Differences and Body Size in Incident Atrial Fibrillation Risk
- Allergen Exposure, Other Factors Predict Limited Airflow in Pediatric Asthma
- Study of Mirasol®-Based Pathogen Reduction in Platelets Fails to Meet Primary Endpoint
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
Omalizumab Outperforms HCQ as Add-on Treatment for Chronic Spontaneous Urticaria
Omalizumab Outperforms HCQ as Add-on Treatment for Chronic Spontaneous Urticaria
Molnupiravir May Be Effective Against COVID-19 in Vaccinated, Unvaccinated Adults
Low fT3/fT4 Ratio Associates With Primary Nonresponse to Infliximab or Adalimumab
Can Injured Third Party File a Malpractice Claim?
